본문 바로가기

기술동향

홈 > BT정보 > 기술동향

scrap print facebook twitter me2day
글 읽기

The Year in Biotech

분류 기술동향 > 종합
출처 http://www.technologyreview.com 조회 2459
자료발간일 2007-12-28 등록일 2007-12-31
내용바로가기 http://www.technologyreview.com/Biotech/19982/
평점 평점이 없습니다.

The Year in Biotech

 

 

Genomics Gets Really Personal
This year may be remembered as the turning point for personal genomics, when broad gene testing for individuals finally came within reach. Two genomic pioneers–James Watson, codiscover of the structure of DNA, and Craig Venter, leader of the private effort to sequence the genome–published the sequence of their own genomes, revealing personal disease risks. (See “The $2 Million Genome” and “Craig Venter’s Genome.”)

 

Taking advantage of the explosion in human genomics data, several companies launched direct-to-consumer gene-testing services that analyze an individual’s genetic risk of contacting a range of diseases, including Alzheimer’s, diabetes, and cancer. (See “Your Future, on a Chip” and “Your Personal Genome.”) Critics say it’s not yet clear how useful such tests will be in preventing disease. So with price tags ranging from about $1,000, for a microarray analysis that analyzes a million genetic variations, to $350,000, for a full genome sequence, it might be worth waiting.

관련기사
Top 10 Non-U.S. Hotspots for Biotech Jobs 2016-11-22
Trump Presidency Impact on Biotechnology 2016-11-21
Biotechnology Leaders Surveyed about Impact of Trump Presiden 2016-11-14
Closing the Gender Gap in Biotech through SBIR/STTR Funding 2016-10-11
[국문홍보책자] Biotechnology in Korea 2016 2016-10-04
Tapping evolution to improve biotech products 2016-09-28
The German Biotechnology Secter 2016 2016-09-28
Top 25 Biotech Companies of 2016 2016-09-27
Biotech Stocks Hold Steady on News of Hillary Clinton's New Drug Price Task Force 2016-09-06
ISPE Europe Conference on BIOTECHNOLOGY 2016-08-29